AAV9-mediated transfer of human Sphingosine-1-phosphate lyase 1 (SGPL1) delivered to newborn Sgpl1 knockout (KO) mice, which normally die in the first few weeks of life, led to prolonged survival and ameliorated pathology, including neurodevelopmental delay, anaemia and hypercholesterolaemia. Here, SGPL1 is linked to anemia (phenotype).